Korean Circ J.
2024 Mar;54(3):156-157. 10.4070/kcj.2024.0056.
Clinical Implication of New-Onset Atrial Fibrillation in the Individuals With Cardiac Implantable Electronic Devices
- Affiliations
-
- 1Second Department of Internal Medicine, University of Toyama, Toyama, Japan
- KMID: 2554144
- DOI: http://doi.org/10.4070/kcj.2024.0056
Reference
-
1. Lee SR, Lee JH, Choi EK, et al. Risk of atrial fibrillation and adverse outcomes in patients with cardiac implantable electronic devices. Korean Circ J. 2024; 54:13–27. PMID: 37973974.2. Darby AE, Dimarco JP. Management of atrial fibrillation in patients with structural heart disease. Circulation. 2012; 125:945–957. PMID: 22354975.3. Kalman JM, Sanders P, Rosso R, Calkins H. Should we perform catheter ablation for asymptomatic atrial fibrillation? Circulation. 2017; 136:490–499. PMID: 28760871.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Author’s Reply to Clinical Implication of New-Onset Atrial Fibrillation in the Individuals With Cardiac Implantable Electronic Devices
- What Does Atrial Fibrillation Mean in Patients With Cardiac Implantable Electronic Devices?
- How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices
- Early Detection of Subclinical Atrial Flutter-Fibrillation in Patients with Unexplained Palpitation Using a Novel VDD Defibrillator with Integrated Atrial-Sensing Rings
- Ventricular Fibrillation in a Patient with Tachycardia-Induced Cardiomyopathy after Liver Transplantation
